Gartner (IT) Q3 2026 Earnings Call Transcript

Gartner reported Q3 2026 adjusted revenue of $1.5 billion, up 3% FX-neutral; adjusted EBITDA rose 8% to $364 million and adjusted EPS increased 30% to $3.59. Total contract value grew 2.5% year over year, accelerating for a third consecutive quarter, and management raised FY 2026 guidance to at least $6.405 billion in revenue, $1.615 billion in EBITDA, and $14.65 in adjusted EPS. Risks include a more difficult selling and retention environment in the Middle East, technology-sector layoffs, and sales cycles that remain longer than historical levels.

Analysis

The quality signal is better than the EPS headline: improving retention and three-quarter contract-value acceleration support a gradual recovery in recurring revenue. But management’s admission that ex-federal growth is unlikely to reach 4% by year-end tempers the near-term reacceleration story. The 30% EPS increase overstates operating momentum: a lower tax rate and a sharply reduced share count amplify results, while analyst hiring is set to put costs back into the P&L over the next several quarters.

AI is a two-sided catalyst. Failed enterprise AI deployments can increase demand for Gartner’s implementation and business-case advice; the counter-risk is that generative tools make research easier to synthesize, pressuring perceived subscription value over time. BTI’s test is not app engagement or document volume, but durable retention and contract expansion sufficient to offset higher analyst costs. Geopolitical weakness, renewed tech layoffs, and extended buying cycles could delay that proof. No valuation or market-expectation data is supplied, so the earnings beat alone does not establish upside.

Key Decisions for Investors

• Treat the release as modestly constructive, not a chase signal. Consider a staged long in Gartner on post-event weakness, contingent on the investment case supporting the entry price; the thesis is retention-led CV acceleration, while the near-term risk is cost normalization before growth improves.
• Track ex-federal contract-value growth, wallet retention, and new business over the next 1–3 quarters. Falsify the recovery thesis if retention reverses or CV acceleration stalls while analyst costs rise; management did not guide to a 4% ex-federal exit rate.
• Do not annualize the EPS acceleration: separate tax-rate benefit and buyback-driven per-share gains from recurring operating growth. Reassess if margin guidance weakens as analyst hiring resumes or free-cash-flow conversion deteriorates.
• Watch for evidence that AI demand converts into paid subscriptions and renewals—not just conference attendance, AskGartner usage, or management-reported interest. Persistent downsell or weaker renewals would strengthen the concern that AI also commoditizes research.